The Supreme Court on Thursday preserved women’s access to a drug used in the most common method of abortion.
The court’s order allows women seeking abortions to continue obtaining the drug, mifepristone, at pharmacies or through the mail, without an in-person visit to a doctor.
Access is likely to remain uninterrupted at least until into next year as the case plays out, including a potential appeal to the high court. The justices granted emergency requests from makers of mifepristone, who are appealing a federal appeals court ruling that would require women to see a doctor in person and halt delivery of mifepristone through the mail.
The federal Food and Drug Administration, which first approved mifepristone for use in abortion in 2000, stopped requiring in-person visits five years ago. Anti-abortion groups, frustrated with President Donald Trump’s administration, are pushing the FDA to move faster with a review that they hope will result in restrictions on mifepristone, including blocking its prescribing via telehealth platforms. The Republican administration says the work takes time.
Earlier this week, FDA Commissioner Marty Makary resigned after months of criticism from Trump’s political allies, including abortion opponents. Susan B. Anthony Pro-Life America and similarly aligned groups had called on Trump to fire Makary over the slow pace of the mifepristone review. The case before the court stems from a lawsuit Louisiana filed to roll back the Food and Drug Administration’s rules on how mifepristone can be prescribed.
The state claims that the policy undermines the ban there, and it questions the safety of the drug, which has repeatedly been deemed safe and effective by FDA scientists. Lower courts concluded that Louisiana is likely to prevail, and a three-judge panel of the 5th U.S. Circuit Court of Appeals ruled that mail access and telehealth visits should be suspended while the case plays out.accounted for nearly two-thirds of all abortions in the U.S. in 2023, the last year for which statistics are available.
Lower courts then also sought to restrict access to mifepristone, in a case brought by physicians who oppose abortion. They filed suit in the months after the court overturned Roe. The Supreme Court blocked the 5th Circuit ruling from taking effect over the dissenting votes of Justices Samuel Alito and Clarence Thomas.
Then, in 2024, the high court unanimously dismissed the doctors’ suit, reasoning they did not have the legal right, or standing, to sue. In the current dispute, mainstream medical groups, the pharmaceutical industry and Democratic members of Congress have weighed in, cautioning the court against limiting access to the drug. Pharmaceutical companies said a ruling for abortion opponents would upend the drug approval process. Debate over the safety of mifepristone has churned for more than 25 years.
The FDA has eased a number of restrictions initially placed on the drug, including who can prescribe it, how it is dispensed and what kinds of safety complications must be reported. Despite those determinations, anti-abortion groups have filed a series of petitions and lawsuits against the agency, generally alleging that it violated federal law by overlooking safety issues with the pill.has been unusually quiet at the Supreme Court.
It declined to file a written brief recommending what the court should do, even though federal regulations are at issue. The case puts the administration in a difficult place. Trump has relied on the political support of anti-abortion groups, but has also seenNurse shot, killed during attempted robbery in DCH hospital parking lotNurse shot, killed during attempted robbery in DCH hospital parking lot2 dead after small plane crashes into Ohio home
Abortion Pill Abortion Pill Mifepristone Access Supreme Court Preserves Access To Widely Used Abor Supreme Court Abortion Pill Supreme Court Abortion Pill Mifepristone Abortion Pill Mifepristone Buying Widely Used Abortion Pill Access To Widely Used Abortion Pill Abortion Pills
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Appeals court pauses Trump’s $83 million payment to E. Jean Carroll pending Supreme Court actionKyla Guilfoil is a breaking news reporter on the politics team for NBC News Digital.
Read more »
Alabama Special Primaries Announced After U.S. Supreme Court Vacates Lower Court OrderFour congressional districts in Alabama will hold special primaries on August 11 after the U.S. Supreme Court vacated a lower-court order requiring the state to use a court-ordered congressional map.
Read more »
22 defendants to appear in court on Thursday in northwest Indiana gambling caseTwenty-two defendants in the northwest Indiana gambling ring investigation are expected to appear in federal court for arraignment on gambling and extortion charges.
Read more »
Supreme Court preserves women's access to abortion drug, rejecting lower-court restrictionsThe Supreme Court on Thursday preserved women's access to a drug used in the most common method of abortion, rejecting lower-court restrictions while a lawsuit continues.
Read more »